Morrisville-based contract research organization Clinipace, has raised $10 million in an equity raise from 16 investors, according to a regulatory filing.

The company, which launched in 2003, is one of the larger CROs, with 800 employees.

Clinipace has raised nearly $90 million in debt and equity since its founding.

Jeff Williams, the co-founder and CEO at Clinipace Worldwide, who was head of the company for 14 years, stepped down in October 2017. Jason Monteleone, who recently launched a financial consulting firm but does have an extensive background in the life science industry, replaced him as CEO.

The company handles regulatory strategies, optimizing clinical development timelines and completing high quality drug and treatment trials. It says it is specifically dedicated to emerging and mid-sized biopharmas.

The company disclosed the raise in a filing with the US Securities and Exchange Commission.